ScientiaCME Contemporary approaches and emerging therapies for the management of respiratory syncytial virus in infants and young high-risk children

Details

Activity Description / Statement of Need:
In this online, self-learning activity:

Respiratory syncytial virus (RSV) is a highly contagious pathogen belonging to the Pneumoviridae family that circulates seasonally with other respiratory viruses. The majority of the population is exposed to RSV, but children under the age of two years and older adults are at the greatest risk of significant morbidity and mortality. RSV infections are responsible for approximately 60-80% of pediatric bronchiolitis and 40% of pediatric pneumonia cases and are a major cause of global hospitalization and mortality. Almost 70% of children are exposed to RSV during their first year of life, and 90% are exposed within their first two years, resulting in an estimated 427,000 emergency department visits and 1.6 million pediatrician visits annually.

Target Audience:
HCPs including: Obstetricians, pediatricians, and family medicine physicians; physician assistants, nurse practitioners, pharmacists specializing in pediatrics; and any other HCPs involved or interested in the management of RSV in infants and high-risk children.